Nifty
Sensex
:
:
19674.25
66009.15
-68.10 (-0.34%)
-221.09 (-0.33%)

Pharmaceuticals & Drugs

Rating :
65/99

BSE: 524500 | NSE: KILITCH

237.25
21-Sep-2023
  • Open
  • High
  • Low
  • Previous Close
  •  229.00
  •  237.40
  •  229.00
  •  226.10
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  37989
  •  89.05
  •  237.40
  •  125.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 373.43
  • 31.86
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 383.80
  • N/A
  • 2.28

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 68.25%
  • 0.75%
  • 27.40%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 3.60%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.23
  • 17.50
  • 28.91

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 14.65
  • 56.91

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.37
  • 7.40
  • 106.16

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 32.48
  • 49.46
  • 38.27

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.43
  • 1.81
  • 1.82

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.63
  • 25.76
  • 26.64

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 23
Jun 22
Var%
Mar 23
Mar 22
Var%
Dec 22
Dec 21
Var%
Sep 22
Sep 21
Var%
Net Sales
36.56
33.45
9.30%
45.48
36.61
24.23%
29.97
34.43
-12.95%
30.70
23.57
30.25%
Expenses
30.38
30.03
1.17%
39.26
31.56
24.40%
25.99
33.67
-22.81%
26.74
19.91
34.30%
EBITDA
6.18
3.42
80.70%
6.21
5.05
22.97%
3.98
0.76
423.68%
3.95
3.66
7.92%
EBIDTM
16.90%
10.22%
13.66%
13.79%
13.28%
2.21%
12.88%
15.52%
Other Income
0.56
0.97
-42.27%
1.02
0.38
168.42%
0.69
1.31
-47.33%
0.24
0.17
41.18%
Interest
1.50
0.67
123.88%
1.21
0.71
70.42%
1.29
0.24
437.50%
1.75
0.12
1,358.33%
Depreciation
0.79
0.82
-3.66%
0.91
1.13
-19.47%
0.93
0.20
365.00%
0.89
0.70
27.14%
PBT
4.45
2.90
53.45%
5.11
3.59
42.34%
2.45
1.64
49.39%
1.55
3.00
-48.33%
Tax
1.39
1.16
19.83%
2.21
1.28
72.66%
0.74
1.02
-27.45%
-0.38
0.42
-
PAT
3.06
1.74
75.86%
2.90
2.30
26.09%
1.71
0.61
180.33%
1.94
2.58
-24.81%
PATM
8.37%
5.19%
6.38%
6.28%
5.70%
1.78%
6.31%
10.95%
EPS
2.15
1.34
60.45%
2.29
1.86
23.12%
1.52
0.72
111.11%
1.56
1.39
12.23%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 12
Mar 11
Net Sales
142.71
114.23
68.52
53.32
82.49
51.01
28.65
20.99
19.03
107.96
146.30
Net Sales Growth
11.44%
66.71%
28.51%
-35.36%
61.71%
78.05%
36.49%
10.30%
-82.37%
-26.21%
 
Cost Of Goods Sold
71.61
65.43
37.31
29.09
48.17
26.00
11.25
8.73
7.02
71.19
100.27
Gross Profit
71.10
48.80
31.22
24.23
34.32
25.01
17.39
12.25
12.01
36.78
46.03
GP Margin
49.82%
42.72%
45.56%
45.44%
41.61%
49.03%
60.70%
58.36%
63.11%
34.07%
31.46%
Total Expenditure
122.37
103.73
63.21
53.33
76.47
45.71
29.20
25.29
20.79
95.34
124.23
Power & Fuel Cost
-
2.00
1.63
1.68
1.48
1.15
1.10
0.97
0.82
6.35
6.56
% Of Sales
-
1.75%
2.38%
3.15%
1.79%
2.25%
3.84%
4.62%
4.31%
5.88%
4.48%
Employee Cost
-
6.18
5.24
5.69
5.28
4.30
3.38
3.47
3.13
6.44
5.62
% Of Sales
-
5.41%
7.65%
10.67%
6.40%
8.43%
11.80%
16.53%
16.45%
5.97%
3.84%
Manufacturing Exp.
-
5.91
3.65
3.55
2.88
2.18
2.73
2.68
1.66
5.98
7.60
% Of Sales
-
5.17%
5.33%
6.66%
3.49%
4.27%
9.53%
12.77%
8.72%
5.54%
5.19%
General & Admin Exp.
-
5.90
5.71
6.32
4.78
3.27
2.80
2.71
2.52
2.04
1.88
% Of Sales
-
5.17%
8.33%
11.85%
5.79%
6.41%
9.77%
12.91%
13.24%
1.89%
1.29%
Selling & Distn. Exp.
-
10.73
7.22
6.20
8.64
5.22
4.71
3.46
2.00
2.02
1.47
% Of Sales
-
9.39%
10.54%
11.63%
10.47%
10.23%
16.44%
16.48%
10.51%
1.87%
1.00%
Miscellaneous Exp.
-
7.58
2.44
0.80
5.24
3.59
3.21
3.27
3.64
1.32
1.47
% Of Sales
-
6.64%
3.56%
1.50%
6.35%
7.04%
11.20%
15.58%
19.13%
1.22%
0.57%
EBITDA
20.32
10.50
5.31
-0.01
6.02
5.30
-0.55
-4.30
-1.76
12.62
22.07
EBITDA Margin
14.24%
9.19%
7.75%
-0.02%
7.30%
10.39%
-1.92%
-20.49%
-9.25%
11.69%
15.09%
Other Income
2.51
2.91
2.67
4.55
5.26
3.27
1.14
2.78
2.72
1.06
0.17
Interest
5.75
1.33
0.88
0.94
0.65
0.42
0.16
0.06
0.05
2.96
3.54
Depreciation
3.52
2.47
1.99
2.00
2.05
2.04
9.76
10.05
1.85
4.87
5.59
PBT
13.56
9.61
5.12
1.61
8.59
6.11
-9.32
-11.63
-0.95
5.84
13.12
Tax
3.96
3.40
1.35
0.77
4.76
0.96
-0.43
-0.44
-0.66
21.05
2.63
Tax Rate
29.20%
35.38%
26.37%
47.83%
55.41%
15.71%
4.61%
3.78%
69.47%
21.62%
20.05%
PAT
9.61
7.36
3.67
0.84
3.83
5.15
-8.89
-11.19
-0.29
76.87
10.56
PAT before Minority Interest
11.72
6.21
3.77
0.84
3.83
5.15
-8.89
-11.19
-0.29
76.31
10.49
Minority Interest
2.11
1.15
-0.10
0.00
0.00
0.00
0.00
0.00
0.00
0.56
0.07
PAT Margin
6.73%
6.44%
5.36%
1.58%
4.64%
10.10%
-31.03%
-53.31%
-1.52%
71.20%
7.22%
PAT Growth
32.92%
100.54%
336.90%
-78.07%
-25.63%
-
-
-
-
627.94%
 
EPS
6.16
4.72
2.35
0.54
2.46
3.30
-5.70
-7.17
-0.19
49.28
6.77

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 12
Mar 11
Shareholder's Funds
139.09
127.13
118.25
121.06
112.03
101.20
108.69
119.88
114.55
84.31
Share Capital
15.58
15.49
15.43
15.36
13.73
13.23
13.23
13.23
13.23
13.23
Total Reserves
120.65
111.28
101.63
104.58
94.56
86.59
94.08
105.27
99.94
69.20
Non-Current Liabilities
-1.24
-0.90
-0.58
-0.62
-1.55
-2.47
-0.95
-0.51
0.82
0.89
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.04
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
Long Term Provisions
0.28
0.38
0.39
0.41
0.00
0.00
0.00
0.00
0.00
0.00
Current Liabilities
69.28
73.32
21.97
20.09
14.92
11.69
7.99
6.85
60.47
66.23
Trade Payables
42.87
53.65
7.10
4.35
7.72
5.68
3.69
2.39
3.66
10.25
Other Current Liabilities
0.57
1.41
1.22
3.89
3.50
3.22
3.35
3.92
1.33
38.00
Short Term Borrowings
20.43
14.80
12.61
9.45
0.92
0.69
0.19
0.00
8.77
15.63
Short Term Provisions
5.41
3.45
1.04
2.40
2.78
2.11
0.77
0.55
46.71
2.35
Total Liabilities
208.34
201.90
141.86
142.63
126.13
110.42
115.73
126.22
176.92
153.00
Net Block
64.54
29.96
31.53
32.13
32.96
33.31
42.41
9.38
8.64
41.93
Gross Block
108.05
71.01
70.59
69.19
67.97
66.28
65.62
22.55
20.78
74.27
Accumulated Depreciation
43.51
41.05
39.06
37.06
35.01
32.97
23.21
13.16
12.14
32.34
Non Current Assets
94.23
121.53
86.08
77.75
63.14
61.85
68.43
79.48
9.61
85.48
Capital Work in Progress
3.16
65.48
29.60
20.25
3.18
0.66
0.00
0.00
0.00
43.15
Non Current Investment
23.93
23.88
24.05
25.02
26.00
27.01
25.82
47.16
0.72
0.22
Long Term Loans & Adv.
0.46
0.44
0.36
0.34
0.22
0.08
0.20
22.94
0.25
0.19
Other Non Current Assets
2.14
1.76
0.54
0.00
0.79
0.79
0.00
0.00
0.00
0.00
Current Assets
114.10
80.36
55.79
64.88
62.98
48.57
47.27
46.72
167.31
67.51
Current Investments
47.23
36.40
27.81
28.42
30.29
26.02
23.12
24.67
137.59
0.00
Inventories
5.00
3.59
5.56
4.72
2.80
2.60
2.62
2.38
2.30
17.02
Sundry Debtors
41.41
22.92
15.86
19.44
20.69
14.61
16.37
12.62
15.03
38.70
Cash & Bank
10.06
12.50
2.80
7.94
4.77
2.29
2.75
4.98
11.67
9.49
Other Current Assets
10.40
0.05
0.04
0.16
4.43
3.05
2.41
2.07
0.73
2.30
Short Term Loans & Adv.
10.04
4.91
3.73
4.21
4.07
2.98
2.38
2.00
0.22
1.30
Net Current Assets
44.83
7.05
33.81
44.78
48.07
36.87
39.28
39.87
106.84
1.28
Total Assets
208.33
201.89
141.87
142.63
126.12
110.42
115.73
126.23
176.92
152.99

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 12
Mar 11
Cash From Operating Activity
5.78
45.66
4.46
0.29
1.42
1.12
17.23
-7.62
-29.35
22.08
PBT
9.61
5.12
1.61
8.59
6.11
-9.32
-11.63
-0.95
-9.69
13.12
Adjustment
3.89
2.80
-1.23
1.87
2.03
11.49
9.17
2.08
7.15
9.14
Changes in Working Capital
-5.19
38.75
6.33
-5.99
-6.70
-1.08
19.71
-8.70
-26.81
-0.17
Cash after chg. in Working capital
8.32
46.67
6.71
4.47
1.44
1.09
17.25
-7.56
-29.35
22.08
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-2.54
-1.01
-2.25
-4.18
-0.02
0.03
-0.02
-0.06
0.00
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-15.25
-37.57
-10.45
-13.98
-4.45
-1.53
-19.57
-31.20
41.02
-23.87
Net Fixed Assets
-8.20
-0.42
-1.00
-1.67
-0.87
-0.66
-0.56
-2.00
96.84
-24.29
Net Investments
-10.88
-8.42
1.58
0.88
-4.21
-4.10
-20.40
68.35
-138.00
-0.71
Others
3.83
-28.73
-11.03
-13.19
0.63
3.23
1.39
-97.55
82.18
1.13
Cash from Financing Activity
7.03
1.61
0.85
16.86
5.51
-0.04
0.11
-0.06
-9.49
7.33
Net Cash Inflow / Outflow
-2.44
9.70
-5.14
3.17
2.48
-0.45
-2.23
-38.87
2.18
5.54
Opening Cash & Equivalents
12.50
2.80
7.94
4.77
2.29
2.75
4.98
43.85
9.49
3.95
Closing Cash & Equivalent
10.06
12.50
2.80
7.94
4.77
2.29
2.75
4.98
11.67
9.49

Financial Ratios

Consolidated /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 12
Mar 11
Book Value (Rs.)
87.43
81.82
75.85
78.11
78.86
75.44
81.07
89.54
85.53
62.30
ROA
3.03%
2.19%
0.59%
2.85%
4.36%
-7.86%
-9.25%
-0.19%
46.26%
7.29%
ROE
4.73%
3.09%
0.71%
3.36%
4.95%
-8.59%
-9.91%
-0.25%
78.03%
13.52%
ROCE
7.26%
4.40%
1.95%
7.59%
6.08%
-8.69%
-10.11%
-0.74%
76.95%
13.06%
Fixed Asset Turnover
1.28
0.97
0.76
1.20
0.76
0.44
0.48
0.88
2.33
2.05
Receivable days
102.77
103.03
120.72
88.79
125.86
197.00
252.10
265.25
88.74
106.38
Inventory Days
13.72
24.29
35.14
16.62
19.22
33.17
43.50
44.88
31.91
36.20
Payable days
269.21
297.22
42.27
32.14
59.43
52.58
37.09
69.84
26.25
31.47
Cash Conversion Cycle
-152.72
-169.89
113.59
73.27
85.65
177.59
258.51
240.30
94.40
111.12
Total Debt/Equity
0.15
0.12
0.11
0.08
0.01
0.01
0.00
0.00
0.08
0.64
Interest Cover
8.22
6.84
2.71
14.25
15.68
-58.98
-183.29
-17.71
33.88
4.71

News Update:


  • Kilitch Drugs(India) - Quarterly Results
    11th Aug 2023, 13:55 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.